BASILEA PHARM.NA SF 1 earnings per share and revenue

PK5 earnings per share for the last semiannual are -1.83 EUR whereas the estimation was -2.16 EUR which accounts for 14.96% surprise. Företagets omsättning för samma period uppgår till 78.41 M EUR trots den uppskattade siffran 77.41 M EUR. Estimated earnings per share for the next semiannual are 1.23 EUR, and revenue is expected to reach 95.49 M EUR. Also watch annual changes over time to get a bigger picture of PK5 earnings per share and revenue dynamics.